Technology Industry
Industry: Email Alert RSS FeedPPGx Inc
BT Catalyst, April, 2000
PPGx Inc. of Morrisville, a joint venture of PPD Inc. of Wilmington and Axys Pharmaceuticals Inc. of South San Francisco Calif., has secured an exclusive worldwide license from St. Jude's Children's Research Hospital in Memphis, Tenn., to test for mutations in the thiopurine Smethyl transferase gene.
- Most Popular Articles in Technology
- An overview of continuous data protection
- Why all those current ratings?
- Many countries now have a mobile penetration rate above 100%, report says
- The Tata Group's big telecom gamble: VSNL's recent acquisition of Tyco ...
- MEASURING BANK BRANCH EFFICIENCY USING DATA ENVELOPMENT ANALYSIS: MANAGERIAL ...
- More »
The test helps physicians identify pediatric leukemia patients with the mutation who often suffer severe reactions to some common anticancer drug treatments. The test will also allow researchers to continue evaluating the mutations of the gene in clinical research.
COPYRIGHT 2000 North Carolina Biotechnology Center
COPYRIGHT 2008 Gale, Cengage Learning